Annual Retained Earnings
-$2.96 B
-$583.20 M-24.52%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual retained earnings is -$2.96 billion, with the most recent change of -$583.20 million (-24.52%) on December 31, 2023.
- During the last 3 years, IBRX annual retained earnings has fallen by -$1.35 billion (-83.37%).
- IBRX annual retained earnings is now -83.37% below its all-time high of -$1.62 billion, reached on December 31, 2020.
Performance
IBRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$3.32 B
-$85.73 M-2.65%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly retained earnings is -$3.32 billion, with the most recent change of -$85.73 million (-2.65%) on September 30, 2024.
- Over the past year, IBRX quarterly retained earnings has dropped by -$85.73 million (-2.65%).
- IBRX quarterly retained earnings is now -105.31% below its all-time high of -$1.62 billion, reached on December 31, 2020.
Performance
IBRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
IBRX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.5% | -2.6% |
| 3 y3 years | -83.4% | -26.0% |
| 5 y5 years | - | -26.0% |
IBRX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.0% | at low | -69.0% | at low |
| 5 y | 5-year | -83.4% | at low | -105.3% | at low |
| alltime | all time | -83.4% | at low | -105.3% | at low |
ImmunityBio Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$3.32 B(+2.7%) |
| Jun 2024 | - | -$3.23 B(+4.3%) |
| Mar 2024 | - | -$3.10 B(+4.5%) |
| Dec 2023 | -$2.96 B(+24.5%) | -$2.96 B(+8.6%) |
| Sep 2023 | - | -$2.73 B(+3.6%) |
| Jun 2023 | - | -$2.63 B(+5.5%) |
| Mar 2023 | - | -$2.49 B(+4.9%) |
| Dec 2022 | -$2.38 B | -$2.38 B(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$2.27 B(+5.1%) |
| Jun 2022 | - | -$2.16 B(+4.6%) |
| Mar 2022 | - | -$2.06 B(+5.2%) |
| Dec 2021 | -$1.96 B(+21.5%) | -$1.96 B(+4.9%) |
| Sep 2021 | - | -$1.87 B(+4.9%) |
| Jun 2021 | - | -$1.78 B(+5.2%) |
| Mar 2021 | - | -$1.69 B(+4.9%) |
| Dec 2020 | -$1.62 B | -$1.62 B |
FAQ
- What is ImmunityBio annual retained earnings?
- What is the all time high annual retained earnings for ImmunityBio?
- What is ImmunityBio annual retained earnings year-on-year change?
- What is ImmunityBio quarterly retained earnings?
- What is the all time high quarterly retained earnings for ImmunityBio?
- What is ImmunityBio quarterly retained earnings year-on-year change?
What is ImmunityBio annual retained earnings?
The current annual retained earnings of IBRX is -$2.96 B
What is the all time high annual retained earnings for ImmunityBio?
ImmunityBio all-time high annual retained earnings is -$1.62 B
What is ImmunityBio annual retained earnings year-on-year change?
Over the past year, IBRX annual retained earnings has changed by -$583.20 M (-24.52%)
What is ImmunityBio quarterly retained earnings?
The current quarterly retained earnings of IBRX is -$3.32 B
What is the all time high quarterly retained earnings for ImmunityBio?
ImmunityBio all-time high quarterly retained earnings is -$1.62 B
What is ImmunityBio quarterly retained earnings year-on-year change?
Over the past year, IBRX quarterly retained earnings has changed by -$85.73 M (-2.65%)